Status | Study |
Not yet recruiting |
Study Name: Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma Condition: Hearing Loss, Cochlear Neurinoma of the Acoustic Nerve Date: 2016-10-26 Interventions: Device: Neuristim Stimulation |
Recruiting |
Study Name: Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Condition: Vestibular Schwannoma Neurofibromatosis Type 2 Date: 2016-10-13 Interventions: Drug: Icotinib Method of drug administration:oral; Dosage: 125mg/m3/d; Course of treatment: 3 months;Tot |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Recruiting |
Study Name: AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas Condition: Neurofibromatosis 2 Meningioma Date: 2016-07-07 Interventions: Drug: AZD2014 |
Recruiting |
Study Name: Resiliency Training for Patients With NF2 Via Videoconferencing With Skype Condition: Neurofibromatosis 2 Date: 2016-06-21 Interventions: Behavioral: Stress Management Group 1 |
Recruiting |
Study Name: Vaccine Therapy in Treating Patients With Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery Condition: Metastatic Malignant Peripheral Nerve Sheath Tumor Neurofibromatosis Type 1 Date: 2016-02-25 Interventions: Procedure: Computed Tomography |
Recruiting |
Study Name: A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery Condition: Malignant Peripheral Nerve Sheath Tumour (MPNST) Date: 2016-02-04 Interventions: Drug: Pembrolizumab Other Name: Keytruda |
Recruiting |
Study Name: Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Condition: High Grade Sarcoma Metastatic Leiomyosarcoma Metastatic Ma Date: 2015-11-09 Interventions: Drug: Pazopanib Hydrochloride |
No longer available |
Study Name: Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients Condition: Neurofibromatosis Type 2 Severe Profound Sensorineural Hearing Loss Date: 2015-10-27 Interventions: Device: Nucleus Profile ABI541 Auditory Brainstem Implant |
Recruiting |
Study Name: PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors Condition: Sarcoma Malignant Peripheral Nerve Sheath Tumors Date: 2015-10-21 Interventions: Drug: PLX3397 PLX3397 is a sel |